Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000902664-25-005061·Pentwater Capital Management LP
Schedule 13G ownership disclosure
VERONA PHARMA PLC
Ordinary Shares, nominal value 0.05 GBP per share · CUSIP: 925050106
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Pentwater Capital Management LP
Shares: 0.00 · Class: 0%
- Matthew Halbower
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-005061
- Form type
- SCHEDULE 13G
- Filer
- Pentwater Capital Management LP
- CIK
- CIK 1425851
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership